These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 16571433

  • 1. Current incidence and outcomes of gastrointestinal mesenchymal tumors including gastrointestinal stromal tumors.
    Perez EA, Livingstone AS, Franceschi D, Rocha-Lima C, Lee DJ, Hodgson N, Jorda M, Koniaris LG.
    J Am Coll Surg; 2006 Apr; 202(4):623-9. PubMed ID: 16571433
    [Abstract] [Full Text] [Related]

  • 2. Association of intratumoral vascular endothelial growth factor expression and clinical outcome for patients with gastrointestinal stromal tumors treated with imatinib mesylate.
    McAuliffe JC, Lazar AJ, Yang D, Steinert DM, Qiao W, Thall PF, Raymond AK, Benjamin RS, Trent JC.
    Clin Cancer Res; 2007 Nov 15; 13(22 Pt 1):6727-34. PubMed ID: 18006774
    [Abstract] [Full Text] [Related]

  • 3. Nursing implications of imatinib as molecularly targeted therapy for gastrointestinal stromal tumors.
    Griffin JM, Amand MS, Demetri GD.
    Clin J Oncol Nurs; 2005 Apr 15; 9(2):161-9. PubMed ID: 15853160
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Does imatinib turn recurrent and/or metastasized gastrointestinal stromal tumors into a chronic disease? - single center experience.
    Armbrust T, Sobotta M, Gunawan B, Füzesi L, Langer C, Cameron S, Ramadori G.
    Eur J Gastroenterol Hepatol; 2009 Jul 15; 21(7):819-23. PubMed ID: 19369884
    [Abstract] [Full Text] [Related]

  • 11. Imatinib mesylate therapy in advanced gastrointestinal stromal tumors: experience from a single institute.
    Hsiao HH, Liu YC, Tsai HJ, Chen LT, Lee CP, Chuan CH, Wang JY, Yang SF, Tseng YT, Lin SF.
    Kaohsiung J Med Sci; 2006 Dec 15; 22(12):599-603. PubMed ID: 17116620
    [Abstract] [Full Text] [Related]

  • 12. Gastric GISTs. Personal experience.
    Mingolla GP, Riccio PA, Linguerri R, La Donna M, Zannelli M, Artuso S.
    Ann Ital Chir; 2007 Dec 15; 78(4):283-8; discussion 288-9. PubMed ID: 17990602
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Outcome of metastatic GIST in the era before tyrosine kinase inhibitors.
    Gold JS, van der Zwan SM, Gönen M, Maki RG, Singer S, Brennan MF, Antonescu CR, De Matteo RP.
    Ann Surg Oncol; 2007 Jan 15; 14(1):134-42. PubMed ID: 17080234
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.